We randomly allocated aneurysmal SAH patients with a modified Fisher score of @ , who had been treated with endovascular coil embolization and ventricular drainage , to receive either @ mg intraventricular tissue plasminogen activator ( TPA ) every @ h ( maximum @ mg ) or placebo .